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cDNA clones for the rat liver and muscle glycogen phosphorylase isozymes have been isolated using iso- 
zyme-selective antibodies and libraries prepared in the expression vector, dgtl 1. A 1.2 kb cDNA coding 
for the carboxy-terminal domain of rat liver phosphorylase was found to have 82% homology with the 
amino acid sequence of rabbit muscle phosphorylase. Limited sequencing of rat muscle phosphorylase 
cDNA indicated a 95% homology with the rabbit muscle enzyme. The rat liver clone has eight additional 
amino acid residues at the COOH-terminus compared to the rat muscle clone. Furthermore, 17 of 26 (65%) 
residues between amino acids 8 15840 differ between liver and muscle isozymes. The similarity in enzymatic 
properties and conservation of structure except at the COOH-terminus suggest hat the liver and muscle 
phosphorylase isozymes do not exist in order to have significant differences in the regulation of glycogen 
breakdown in the two tissues. Rather, the phosphorylase isozymes probably evolved for tissue-specific tran- 
scriptional regulation of the genes in liver and muscle. 
Phosphorylase Isozyme 
1. INTRODUCTION 
Glycogen phosphorylase (EC 2.4.1.1) catalyzes 
the first step in the intracellular degradation of 
glycogen. The amino acid sequence of the enzyme 
from rabbit skeletal muscle has been determined 
[l] and the crystal structure defined at 2.5 A 
resolution [2,3]. Extensive investigation has de- 
fined the allosteric effecters and covalent 
phosphorylation involved in the acute regulation 
of phosphorylase (review [3-51). Phosphorylase 
levels are regulated in both muscle and liver. For 
example, in developing muscle cultures phospho- 
rylase activity increases following fusion of rat 
myoblasts into myotubes [6,7]. Phosphorylase ac- 
tivity also changes significantly between birth and 
weaning [8], in muscles of different fiber type 
* To whom correspondence should be addressed 
cDNA (Rat, Liver, Muscle) 
[g-12], and with changes in muscle activity 
[ 13-151. Total phosphorylase activity in liver is 
markedly depressed in the diabetic state [ 16- 181, 
and evidence exists that triiodothyronine and in- 
sulin may be involved in regulating the expression 
of phosphorylase in hepatocyte primary cultures 
[19,20]. 
Phosphorylase exists as immunologically 
distinct isozyme forms in muscle and liver [2 l-231. 
We report here the isolation of partial cDNA 
clones for both the rat liver and muscle isozyme 
forms of phosphorylase using isozyme-selective 
antibodies and Agtll expression libraries. The 
cDNA clones allow analysis of phosphorylase 
mRNA expression in muscle and liver during the 
developmental and metabolic changes that have 
been previously defined only at the level of total 
enzyme activity. 
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2. MATERIALS AND METHODS 
Glycogen phosphorylase was purified from rat 
liver and heart using modifications of published 
procedures [24]. Silver staining of SDS-acrylamide 
gels after electrophoresis of the purified enzymes 
from both tissues yielded a single band indicating 
the preparations were essentially homogeneous. 
Purified phosphorylase from the two rat tissues 
was independently used to immunize sheep. Initial 
immunizations were in complete Freund’s adju- 
vant and boosts were performed in incomplete 
Freund’s adjuvant at three week intervals. After 
the second boost the animals were bled one week 
later and serum tested for phosphorylase an- 
tibodies by Western blotting [25,26] and inhibition 
of enzyme activity. Positive serum was used for the 
affinity purification of phosphorylase antibodies. 
Purified liver or heart phosphorylase was coupled 
to CNBr-activated Sepharose (Pharmacia) using 
the manufacturer’s instructions. The appropriate 
serum was repeatedly passed over the 
phosphorylase-Sepharose affinity column and 
washed extensively with phosphate-buffered 
saline. Adsorbed antibodies were eluted at pH 2.8 
and immediately neutralized to pH 7.4 using 0.5 M 
sodium phosphate and then dialyzed extensively 
against 150 mM sodium phosphate, pH 7.4. 
Eluted antibodies were shown to recognize specific 
isozymes of phosphorylase by comparison of 
Western blots of crude homogenates of rat liver 
and heart and the purified enzymes as well as in- 
hibition of phosphorylase activity. Purified 
isozyme-selective antibodies recognized a single 
protein of 92.5 kDa from the appropriate tissue 
from which the phosphorylase was purified. 
Isozyme cross-reactivity with the purified an- 
tibodies determined by Western blotting was 10% 
or less of the reactivity toward the isozyme form 
used for immunization. The isozyme-specific 
phosphorylase antibodies were further purified by 
passing through a column prepared by coupling a 
crude homogenate from Escherichia coli strain 
Y1090 to CNBr-activated Sepharose. The flow 
through containing the phosphorylase antibodies 
was used to screen Agtll expression libraries [27] 
for the isolation of isozyme-specific phosphorylase 
cDNA. 
Recombinant phages were adsorbed to E. coli 
strain Y1090 and plated at a density of 8-10000 
plaque forming units per 15 cm LB-ampicillin 
plate with X-Gal and grown for approx. 4 h at 
42°C as described by Young and Davis [27]. 
Nitrocellulose filters which had been previously 
soaked in IPTG followed by air drying were laid 
over the plates and fl-galactosidase fusion protein 
synthesis was induced for 2 h at 37°C. Replica 
filters were washed and prepared for antibody 
blotting essentially by methods described previous- 
ly [27,28]. Positive clones obtained in the first 
high-density screen were picked and taken through 
three successive rounds of antibody screening at 
low plaque density. The plaque purified positive 
clones were then used for large scale preparation of 
phage [27,28]. Isolated DNA was digested with 
EcoRI endonuclease and fractionated by agarose 
gel electrophoresis. Insert cDNA was subcloned in- 
to the M13Mp18 and M13Mp19 phage and se- 
quenced using the dideoxy method of Sanger et al. 
WI - 
The rat skeletal muscle cDNA library was con- 
structed in hgtll using the methods described by 
Huynh et al. [30]. Skeletal mulscle RNA was 
isolated by modification of the guanidinium 
isothiocyanate procedure of Chirgwin et al. [31]. 
Rats were killed by decapitation and skeletal mus- 
cle quickly removed for homogenization in 
guanidinium isothiocyanate. Following homogeni- 
zation, sodium N-laurylsarcosine to a final concen- 
tration of 4% and 0.25 g CsCl/ml homogenate 
were added, and the samples layered onto 5 ml 
cushions of 5.7 M CsCl in 100 mM EDTA and 
centrifuged for 24 h in a SW28 rotor. RNA pellets 
were resuspended in SDS buffer (50 mM Tris-HCl, 
pH 7.5, 10 mM EDTA, 0.1% SDS) and heated 
briefly to 68°C. RNA was extracted with phenol/ 
SDS buffer/chloroform (1: 1: l), then chloro- 
form alone (1: 1) and then ethanol precipitated. 
Poly(A)+ RNA was isolated by oligo-dT cellulose 
chromatography and used for preparation of 
cDNA. The rat liver cDNA library in hgt 11 was a 
generous gift from Drs J. Schwarzbauer and R. 
Hynes [28]. 
3. RESULTS AND DISCUSSION 
To isolate phosphorylase isozyme cDNAs, 
phage Agt 11 expression libraries prepared using rat 
liver [28] or skeletal muscle RNA were screened us- 
ing affinity-purified antibodies raised against 
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phosphorylase from the appropriate rat tissue. tibodies. Fig.2 shows a representative analysis of 
Fig.1 shows Western blots demonstrating that the the fusion proteins from the purified clones. 
antibody raised against liver phosphorylase has a Lysogens from control Xgt 11 and clones containing 
strong selectivity for the liver isozyme, with a positive immunoreactive proteins were prepared 
relatively weak cross-reactivity with the heart and and induced with IPTG. Lysates were separated on 
skeletal muscle phosphorylase protein. The an- SDS-acrylamide gels and subsequently analyzed by 
tibody raised against rat heart phosphorylase blotting with isozyme-selective antibodies. The 
shows a similar selectivity, with a strong preference major immunoreactive proteins with both the liver 
for the heart and skeletal muscle enzyme and weak and muscle phosphorylase antibodies were the fu- 
cross-reactivity with the liver isozyme. sion proteins inducible by IPTG. Fig.2B shows a 
phosphorylase clone (Alp 1 ) isolated from the rat Initial plaque screening of approx. 3.2 and 1.6 x 
lo5 independent liver and muscle clones, respec- 
tively, gave four putative liver clones and two 
putative muscle clones. The positive clones were 
purified and rescreened with the appropriate an- 
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Fig. 1. Isozyme-selective antibody blotting to rat liver, 
heart and skeletal muscle glycogen phosphorylase. 
10000 x g supernatants of rat liver (L), heart (H) and 
skeletal muscle (S) were electrophoresed on 7.5% 
acrylamide-SDS gels [26]. Proteins were then 
electrophoretically transferred to nitrocellulose and 
incubated with purified anti-heart or liver phosphorylase 
antibodies. The filters were incubated first with rabbit- 
anti-sheep IgG, then in ‘251-protein A (10’ cpm/ml). 
Both incubations were in a buffer containing 10 mM 
Tris-HCl, pH 7.5, 150 mM NaCl (Tris buffer) and 
0.25% BSA. Washes in Tris buffer with or without 
0.05% NP-40 followed each incubation. Lanes: l-4, 
Coomassie blue profiles of molecular mass standards 
and liver, heart and skeletal muscle extracts; 5-10, 
autoradiograms of Western blots developed using the 
isozyme-selective phosphorylase antibodies. 
'd,, 
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Fig.2. Characterization of phosphorylase cDNA clones 
by antibody blotting to P-galactosidase-phosphorylase 
fusion proteins. Bacterial lysates were prepared from the 
control lysogen Y 1089/Agt 11 (lanes 1 and 2) and lysogen 
Y 1089/Alpl (lanes 3 and 4) following inactivation of the 
repressor at 42°C and subsequent incubation in the 
absence (lanes 1 and 3) or presence (lanes 2 and 4) of 
IPTG [27,28]. (A) The Coomassie blue staining profile 
of 7.5% acrylamide-SDS gels of the lysates. (B) The 
Western blot of a duplicate gel of (A) transferred to 
nitrocellulose and blotted with the liver-selective 
phosphorylase antibody. (C) Western blotting of liver 
and heart phosphorylase isozyme-selective antibodies to 
&galactosidase-phosphorylase fusion protein. Equal 
amounts of the lysate containing the Alp1 fl- 
galactosidase-phosphorylase fusion protein shown in 
panels A and B (lane 4) were electrophoresed on 7.5% 
acrylamide-SDS gels and transferred to nitrocellulose. 
Nitrocellulose strips were then blotted with purified 
antibodies raised against either liver (lane 1) or heart 
(lane 2) phosphorylase. The heart antibody binding to 
the hlpl fusion protein was approx. 8%lo-fold less than 
the liver antibody. 
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liver library and is representative of the inducibility 
of fusion proteins using IPTG following these pro- 
tocols. The fusion protein of clone hlpl (lanes 3 
and 4) shows a strong immunoreactivity with the 
rat liver phosphorylase antibody. Importantly, 
clone hlpl demonstrated the isozyme selectivity of 
the purified liver phosphorylase antibody. This is 
demonstrated in the Western blots shown in fig.ZC 
using the liver- and muscle-selective antibodies and 
lysates from the IPTG-induced Alp1 clone. This 
finding indicated that a major isozyme antigenic 
domain was within the cDNA insert present in hlpl 
which coded for a peptide of approx. 10 kDa. The 
insert in hlpl was sequenced and the deduced 
amino acid sequence showed very strong homology 
with the carboxy-terminal domain of rabbit 
skeletal muscle phosphorylase confirming this as a 
phosphorylase cDNA (see figs 3 and 4). 
The remaining liver clones and the two muscle 
clones were further analyzed by restriction map- 
ping and DNA sequencing. The largest inserts 
identified were 1.2 kb (Alp2) and 1.1 kb (hmpl) for 
liver and muscle, respectively. Fig.3 shows the 
alignment of these two clones based on this 
analysis. All of the clones overlapped significantly 
coding for the carboxy-terminal region of 
phosphorylase, and contained at least one major 
isozyme antigenic domain as demonstrated by 
Western blotting of the induced fusion proteins. 
The inserts of two liver clones Alp1 and hlp2 
were entirely sequenced and two muscle clones 
hmpl and Amp2 partially sequenced as outlined in 
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Fig.4. Partial nucleotide sequence and deduced amino 
acid sequence of the rat liver and muscle phosphorylase 
isozymes and comparison with the rabbit muscle 
enzyme. Amino acids in letter notation are numbered 
beginning with residue 440 of the rabbit muscle 
phosphorylase protein. Dashes, identity in amino acids 
for the rat liver (L) or rat muscle (M) clones with the 
rabbit muscle sequence; underlined sequence, site used 
for a phosphorylase-complementary oligomer during 
sequencing of the liver and muscle cDNAs; asterisk, stop 
Fig.3. Sequencing strategy for phosphorylase cDNAs 
from muscle and liver. Restriction endonuclease 
designations: BarnHI (B), Hind111 (H) and KpnI (K). 
Ends of Alp2 and Amp1 inserts were at EcoRI sites. 
Asterisk, a sequencing reaction performed using a 
phosphorylase-complementary oligomer as primer. codon for the rat liver cDNA. 
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fig.3. Fig.4 shows the determined nucleotide se- 
quence and deduced amino acid sequence for the 
rat liver and muscle clones in comparison to the 
rabbit skeletal muscle primary sequence [l]. Based 
on the partial cDNA sequence and the known 
amino acid sequence of the rabbit skeletal muscle 
enzyme, several facts are evident. Comparison of 
the determined rat liver sequence with the rabbit 
muscle amino acid sequence indicates an 82% 
homology. The limited rabbit muscle phosphory- 
lase nucleotide sequence information obtained by 
Putney et al. [32] and Hwang et al. [33] indicates 
a 68 and 64% homology, respectively, with the 
corresponding rat liver phosphorylase domain. 
The limited rat muscle sequence we obtained is 
95% homologous with the rabbit muscle sequence. 
Comparison of the overlapping region sequenced 
for the rat liver and muscle clones shows a 79% 
amino acid homology and a 74% conservation at 
the nucleotide level. The difference between amino 
acid and nucleotide conservation appears to be due 
12345678 
286 
to a bias in codon usage between the two tissues. 
The majority of amio acid substitutions are 
predicted to have little effect on the structure and 
properties of the enzyme. A striking difference in 
the amino acid sequence between the rat liver and 
muscle sequences was found at the COOH- 
terminus. The muscle clone terminates at residue 
840 (isoleucine) [33], whereas the liver clone (fig.4) 
has eight additional amino acids terminating with 
a lysine (residue 848). Furthermore, between 
residues 815-840, 17 of 26 amino acids (65%) dif- 
fer between the liver and muscle clones. This dif- 
fers from the overall 80% conservation of amino 
acid sequence determined for liver and muscle 
clones. Whether this significant deviation in amino 
acid sequence at the carboxy-terminus of liver and 
muscle phosphorylase is related to a functional dif- 
ference between the two isozymes has yet to be 
defined. 
Northern analysis shown in fig.5 indicates the 
size of the liver and muscle phosphorylase mRNA 
to be 3.1 and 3.2 kb, respectively. Based on the 
size of the phosphorylase mRNA and translated 
Fig.5. RNA blot of glycogen phosphorylase mRNAs. 
RNA was isolated from rat liver (L) and heart (H) by 
guanidinium isothiocyanate precipitation by the method 
of Chirgwin et al. [31]. Poly(A)+ RNA was purified by 
two cycles of oligo(dT)-cellulose chromatography. 
Poly(A)+ RNA was heated at 60°C for 5 min in 50% 
formamide and 6.5% formaldehyde. After addition of 
10 x loading buffer (50% glycerol/l0 mM EDTA/0.4% 
bromophenol blue/0.4% xylene cyanol) in l/10 of the 
sample volume, the RNA was separated by 
electrophoresis on a 0.8% agarose gel containing 6% 
formaldehyde, 1 mM EDTA, 5 mM sodium acetate and 
20 mM Mops, pH 7.0. RNA was transferred to Z-probe 
(Bio-Rad) according to Thomas [37]. Filters were 
prehybridized with 50% formamide, 5 x SSC, 5 x 
Denhardt’s solution, 200 pg/ml salmon sperm DNA and 
0.5% SDS for 8 h at 42°C. Hybridization was 
performed with 5 x 10’ cpm nick-translated probe 
(> 10’ cpm/pg) in 50% formamide, 5 x SSC, 1 x 
Denhardt’s solution, 10% dextran sulfate and 20 mM 
sodium phosphate, pH 6.5, for 15 h at 42°C. Filters 
were washed 3 times with 2 x SSC and 0.1% SDS for 
10 min at 24°C and then twice with 0.1 x SSC and 0.1% 
SDS for 10 min at 50°C. Blots were exposed to Kodak 
X-Omat film at -70°C overnight. Closed arrowheads 
indicate a 3.1 and 3.2 kb mRNA and the open 
arrowhead indicates a 3.4 kb mRNA. 
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proteins it is predicted that each mRNA contains 
550-650 bases of noncoding region. In addition to 
the 3.1 kb liver mRNA, both the hlpl and Alp2 
clones detected a second mRNA species approx. 
300 bases larger. Further analysis will be required 
to determine the relationship between this RNA 
species and the major 3.1 kb liver phosphorylase 
mRNA. Despite the homologies observed in the 
nucleotide sequences, high stringency conditions 
could be used with both the liver and muscle cDNA 
probes to measure isozyme-specific mRNA in the 
appropriate tissues. This finding indicates the 
usefulness of these probes for characterizing the 
expression of isozyme-specific phosphorylase 
mRNA in muscle and liver. Fig.6 shows the 
Southern analysis of rat genomic DNA using liver 
and muscle phosphorylase isozyme-specific 
probes. The differences in the intensity and pattern 
of hybridization for BumHI, KpnI and PstI 
restricted genomic DNA indicated that at least two 
genes for phosphorylase are present in the rat 
genome. The fact that the isozymes are coded for 
by different genes is also indicated by the dif- 
ferences in nucleotide sequence for the liver and 
muscle clones (fig.4). 
Our results indicate that the rat phosphorylase 
cDNA probes will be useful for studying tissue- 
specific isozyme expression of the key regulatory 
enzyme involved in glycogen breakdown. The 
significant conservation of phosphorylase se- 
quences between rat isozymes, the rabbit skeletal 
muscle enzyme [32,33] and phosphorylases 
characterized from other species [34] suggests that 
the expression of the phosphorylase isozyme genes 
is related to tissue-specific gene expression 
mechanisms and probably not for major dif- 
ferences in the regulatory properties of the enzyme 
in liver and muscle. The similarities in allosteric 
regulation of the enzyme in muscle and liver sup- 
port this hypothesis. Our studies take on added im- 
portance since glycogen synthase, the regulated en- 
zyme in glycogen synthesis, also exists as isozyme 
forms in muscle and liver [35]. We are presently 
isolating the cDNA for glycogen synthase to ex- 
amine the regulation of expression of the two 
glycogen metabolizing enzymes in muscle and 
liver. Other isozyme systems such as creatine 
kinase have also been shown to have very closely 
related sequences [36], similar to our findings of 
tissue-specific transcriptional regulation of genes 
Fig.6. Hybridization of rat liver (Mp2) and muscle 
(Ampl) probes to restriction digests of rat genomic 
DNA. High molecular mass genomic DNA was prepared 
from rat hepatocytes by the method of Gross-Bellard et 
al. [38]. The genomic DNA was digested with BarnHI 
(lanes 1 and 6), EcaRI (lanes 2 and 7), Hind111 (lanes 3 
and 8), KpnI (lanes 4 and 9) or PstI (lanes 5 and 10) size- 
fractionated on a 0.7% agarose gel and transferred toZ- 
probe. The filters were prehybridized for 6 h at 6YC in 
6 x SSC, 0.6% SDS, 5 x Denhardt’s olution and 
IOOpg/mI salmon sperm DNA. The Southern genomic 
blot was hybridized with IO6 cpm/ml nick-translated 
DNA probe for 15 h at 42’C in the same hybridization 
buffer described in fig.5 for the RNA blot. Filters were 
then washed twice with 2 x SSC and 0.1% SDS for 1 h 
at 24°C and then 3 times with 0.2 x SSC and 0.1% SDS 
for 30 min at 55°C. Arrows indicate differences in 
hybridization with the Alp2 liver and Amp1 muscle 
clones. 
coding for highly conserved phosphorylase en- 
zymes. Availability of suitable cDNA probes for 
phosphorylase allows us to begin to address this 
problem for the enzymes involved in glycogen 
metabolism and how this differential expression is 
controlled in development and altered in the 
diabetic animal. 
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